Advice
following an abbreviated submission
levonorgestrel (Levosert®) intrauterine delivery system is accepted for use within NHS Scotland.
Indication under review: Contraception. Heavy menstrual bleeding.
Levosert® may be particularly useful in women with heavy menstrual bleeding requiring (reversible) contraception.
Levosert® intrauterine delivery system (IUS) contains the same total amount of levonorgestrel with the same release profile as an existing levonorgestrel-containing IUS at a lower unit cost.
Download detailed advice50KB (PDF)
Medicine details
- Medicine name:
- levonorgestrel (Levosert)
- SMC ID:
- 1058/15
- Indication:
- Contraception. Heavy menstrual bleeding.
- Pharmaceutical company
- Actavis
- BNF chapter
- Obstetrics, gynaecology, and urinary-tract disorders
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 08 June 2015